Assignee
BIAL - PORTELA & CA S A
PT·15 granted patents·1 pending application·47 citations·filing 2005–2019
Top patents by PatentIndex Score
16 records- 0185US10357468B2Medicaments for slowing Parkinson's diseaseBIAL—PORTELA & CA S A·Filed 2015·Granted Jul 23, 2019·8 cites·21 claims
- 0285US9550759B2Nitrocatechol derivatives as COMT inhibitorsBIAL—PORTELA & CA S A·Filed 2014·Granted Jan 24, 2017·5 cites·8 claims
- 0385US9446012B2Pharmaceutical compoundsBIAL-PORTELA & CA S A·Filed 2013·Granted Sep 20, 2016·7 cites·14 claims
- 0482US9763954B2Therapeutical uses of eslicarbazepineBIAL-PORTELA & CA S A·Filed 2013·Granted Sep 19, 2017·4 cites·28 claims
- 0582US9549915B2Urea compounds and their use as enzyme inhibitorsBIAL-PORTELA & CA S A·Filed 2013·Granted Jan 24, 2017·6 cites·5 claims
- 0681US9745290B2Dosage regimen for COMT inhibitorsBIAL—PORTELA & CA S A·Filed 2015·Granted Aug 29, 2017·3 cites·15 claims
- 0780US10065944B2Administration regime for nitrocatecholsBIAL—PORTELA & CA S A·Filed 2013·Granted Sep 4, 2018·5 cites·6 claims
- 0879US10071085B2Pharmaceutical formulations comprising nitrocatechol derivatives and methods of making thereofBIAL—PORTELA & CA S A·Filed 2015·Granted Sep 11, 2018·4 cites·20 claims
- 0976US10336740B2Nitrocatechol derivatives as COMT inhibitorsBIAL—PORTELA & CA S A·Filed 2017·Granted Jul 2, 2019·1 cites·16 claims
- 1073US9630951B21,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylaseBIAL-PORTELA & CA S A·Filed 2013·Granted Apr 25, 2017·1 cites·14 claims
- 1170US7999100B2Method for chiral inversion of (S)-(+)-and (R)-(−)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereofBIAL PORTELA CA & S A·Filed 2005·Granted Aug 16, 2011·2 cites·28 claims
- 1266US9604970B21,3-dihydroimidazole-2-thione derivatives for use in the treatment of pulmonary arterial hypertension and lung injuryBIAL—PORTELA & CA S A·Filed 2013·Granted Mar 28, 2017·1 cites·19 claims
- 1360US11034695B2Dopamine-β-hydroxylase inhibitorsBIAL—PORTELA & CA S A·Filed 2017·Granted Jun 15, 2021·0 cites·25 claims
- 1458US2017369478A11,3-dihydroimidazole-2-thione derivatives as inhibitors of dopamine-beta-hydroxylaseBIAL - PORTELA & CA S A·Filed 2017·Application pending·0 cites
- 1552US12097193B2Methods for the administration of COMT inhibitorsBIAL—PORTELA & CA S A·Filed 2019·Granted Sep 24, 2024·0 cites·11 claims
- 1651US10308640B21,3-dihydroimidazole-2-thione derivatives for use in the treatment of pulmonary arterial hypertension and lung injuryBIAL—PORTELA & CA S A·Filed 2017·Granted Jun 4, 2019·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when BIAL - PORTELA & CA S A files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →